| Upgrade to PrivCo Premium |
| Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
|
|
| Upgrade to PrivCo Premium |
| Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
|
|
Novo Nordisk Biotech Fund is a Bagsvaerd, Denmark-based venture capital firm. Novo Nordisk Biotech Fund considers seed and early stage investments.
| Investor Type: | Venture Capital |
| Address: | Novo Alle, 6A1.004 |
| City: | Bagsvaerd |
| Country: | Denmark |
| Phone: | View |
| Website: | www.biotechfund.novonordisk.com |
| Preferred Stage: | Seed Early Stage Mid Stage / Expansion |
| Name | Title | |
| Johannes Jensen | VP | E-mail Johannes Jensen Directly |
| Jacob Falck Hansen | Investment Associate | E-mail Jacob Falck Hansen Directly |
| Date | Target | Target Industry | Deal Type | Total Deal Amount | Status | |
| Oct. 2012 | View | Biotechnology | Funding | View | Completed | Details |
| Apr. 2010 | View | Biotechnology | Funding | View | Completed | Details |
| May. 2009 | View | Drug Delivery Technology Pharmaceuticals | Funding | View | Completed | Details |
| Oct. 2007 | View | Other Biotechnology | Funding | View | Completed | Details |
| Upgrade to PrivCo Premium |
| Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
|
|